ConnectureDRX
Brookfield, US · 3 known investors
ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. The company offers analytics and data-driven solutions to help healthcare organizations engage members and navigate Medicare complexities.
Founders & leadership
LD
Lea DeVillersinGeneral Counsel2010–2020
DA
David A. SockelinEVP, Strategy and Product Development2015–2018
JA
Jeffrey A. SurgesExecutive
ME
Mark E. GranvilleExecutive
JP
James P. PurkoinChief Financial Officer2011–2016
RD
Robert Douglas SchneiderExecutive
AT
Andrew TutajinPresident & EVP
BL
Becky LonginVP, Customer Success
MM
Mike MieureinVP, Technology and Security
DW
David WestoninVP, Operations
Board
EP
Ezra PerlmanBoard director
DA
David A. Jones, Jr.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$69.5M disclosed across 2 rounds · 2016–2017
▶$17.5MraisedMar 2017 · 3 investors · Other TechnologyRule 506(b)
▶$17.5MraisedMar 2017 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David A. Jones, Jr.Director
- David A. SockelExecutive Officer
- Vickie L. CappsDirector
- Lea DeVillersExecutive Officer
- Mark E. GranvilleExecutive Officer
- Paul KusserowDirector
- Vincent E. EstradaExecutive Officer
- Ezra PerlmanDirector
- Russell S. ThomasDirector
- A. John AnsayDirector
- Jeffery A. SurgesExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Finders' fees
- $150K
- Placement agents
- Raymond James & Associates, Inc.
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$52MraisedMay 2016 · 3 investors · Other TechnologyRule 506(b)
▶$52MraisedMay 2016 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Lea DeVillersExecutive Officer
- David A. SockelExecutive Officer
- Jeffrey A. SurgesExecutive Officer, Director
- Ezra PerlmanDirector
- Mark E. GranvilleExecutive Officer
- Vickie L. CappsDirector
- A. John AnsayDirector
- James P. PurkoExecutive Officer
- David A. Jones, Jr.Director
- Robert Douglas SchneiderExecutive Officer
- Paul KusserowDirector
- Russell S. ThomasDirector
- Offering amount
- $52M
- Amount sold
- $52M
- Finders' fees
- $1.5M
- Placement agents
- Raymond James & Associates, Inc.
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsDestinationRx
Developer of drug comparison and purchasing tools; acquired by Connecture in 2013.
Frequently asked questions
- What does ConnectureDRX do?
- ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. The company offers analytics and data-driven solutions to help healthcare organizations engage members and navigate Medicare complexities.
- Who are ConnectureDRX's investors?
- ConnectureDRX's investors include Atlanta Technology Angels, Scientia Ventures, Chrysalis Ventures.
- How much funding has ConnectureDRX raised?
- ConnectureDRX has disclosed $69.5M raised across 2 rounds.
- Where is ConnectureDRX headquartered?
- ConnectureDRX is headquartered in Brookfield, US.